|
|
1.
|
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1. MedStar authors:
Citation: - New England Journal of Medicine. 373(8):714-25, 2015 Aug 20.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Infectious Diseases
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Ackerman P, ALLY-2 Investigators, Dieterich D, Dretler R, Fishbein D, Gathe JC Jr, Henn S, Hinestrosa F, Hughes E, Huynh C, Liu Z, Luetkemeyer A, McDonald C, McPhee F, Mills A, Morgan TR, Noviello S, Overton ET, Ramgopal M, Rashbaum B, Ray G, Ruane PJ, Scarsella A, Sherman KE, Sulkowski MS, Wyles DL, Yin PD, Yozviak J
|
|
|
2.
|
Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C. MedStar authors:
Citation: - Gut. 63(1):161-9, 2014 Jan.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Gastroenterology
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Intramural
- Research Support, Non-U.S. Gov't
All authors: - Abdalla A, Ahlenstiel G, Dahari H, Doo E, Edlich B, Feld JJ, Gara N, Ghany MG, Guedj J, Han H, Heller T, Hogdal L, Hoofnagle JH, Koh C, Liang TJ, Noureddin M, Park SH, Park YJ, Perelson AS, Rehermann B, Rotman Y, Sarkar S, Thomas E, Titerence R, Witthaus M
|
